FDA revokes EUA for monoclonal antibody therapy bamlanivimab to treat patients with COVID-19

Retrieved on: 2021-04-17 17:37:30

Tags for this article:

Click the tags to see associated articles and topics

FDA revokes EUA for monoclonal antibody therapy bamlanivimab to treat patients with COVID-19. View article details on hiswai:

Excerpt

Monoclonal antibodies are laboratory-made proteins that mimic the immune system's ability to fight off harmful pathogens such as viruses, like ...

Article found on: www.news-medical.net